Short report: No evidence of cardiotoxicity of atovaquone-proguanil alone or in combination with artesunate

American Journal of Tropical Medicine and Hygiene

Volumn 73, Issue 2, 2005, Pages 267-268

  Gupta, Ravindra K ^b,c   Van Vugt, Michele ^b,d   Paiphun, Lucy ^b,d   Slight, Thra ^b   Looareesuwan, Sornchai ^d   White, Nicholas J ^d,e   Nosten, François ^a,b,d,e  

^a Shoklo Malaria Research Unit ^*  (Thailand)

^b SHOKLO MALARIA RESEARCH UNIT   (Thailand)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d MAHIDOL UNIVERSITY   (Thailand)

^e JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTESUNATE; ATOVAQUONE; PROGUANIL;

ADOLESCENT; ADULT; ARTICLE; BLOOD SMEAR; CARDIOTOXICITY; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; HUMAN; MALARIA; MALARIA FALCIPARUM; MALE; MIGRANT WORKER; PLASMODIUM FALCIPARUM; QT INTERVAL; RANDOMIZED CONTROLLED TRIAL; REFUGEE; THAILAND; TREATMENT OUTCOME;

ARTESUNATE; PLASMODIUM FALCIPARUM;

EID: 24644463768     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2005.73.267     Document Type: Article

References (6)

1. Trape JF, Pison G, Spiegel A, Enel C, 2002. Combating malaria in Africa. Trends Parasitol 18: 224-230.
2. van Vugt M, Leonardi E, Phaipun L, Slight T, Thway K, McGready R, Brockman A, Villegas L, Looareesuwan S, White NJ, Nosten F, 2002. Treatment of uncomplicated multidrug resistant falciparum malaria with artesunate-atovaquone- proguanil. Clin Infect Dis 15: 1498-1504.
3. Karbwang J, Davis T, Looareesuwan S, Molunto P, Bunnag D, White NJ, 1993. A comparison of the pharmacokinetic and pharmacodynamic properties of qunine and quinidine in healthy Thai males. Br J Pharmacol 35: 265-271.
4. Nosten F, ter Kuile F, Luxemburger C, Woodrow C, Kyle D, Chongsuphajaisiddhi T, White NJ, 1993. Cardiac effects of antimalarial treatment with halofantrine. Lancet 341: 1054-1056.
5. van Vugt M, Ezzet F, Nosten F, Gathmann I, Wilairatna P, Looareesuwan S, White NJ, 1999. No evidence of cardiotoxicity during antimalarial treatment with artemether-lumefantrine. Am J Trop Med Hyg 61: 964-967.
6. ter Kuile F, Nosten F, Luxemburger C, Kyle D, Teja-Isavatharm P, Phaipun L, Price R, Chongsuphajaisiddhi T, White NJ, 1995. Mefloquine treatment of acute falciparum malaria: a prospective study of non-serious adverse effects in 3673 patients. Bull World Health Organ 73: 631-642.